By DJ Edgerton
Back in September, Mike shared his digital reading list – newspapers, websites, newsletters and blogs that he loved. We’ve also given you lists of bloggers, Twitterers – even conferences that we think are worth your eyeballs.
But now we’re going to go back. Way back. All the way back to… Paper. That’s right. Just [...]
Tags:#pnpsm·communication·contest·Education·marketing·media·Pharma·social media·Thought Leaders·Twitter
We’ve got a lot to be thankful for at Pixels and Pills and we hope you do as well. P & P will be taking a short holiday break but we’ll be back on Monday, November 30th with some exciting news.
Until then, we wish you and yours a very Happy Thanksgiving.
Tags:
By Guy Mastrion
An article in a recent issue of WIRED cited statistics that the placebo effect is twice as strong as it used to be.
Is it really, I wondered? I guessed not. I guessed that there was a good reason for it. And I came up with a couple of possibilities.
First possibility. What if we [...]
Tags:brain-body relationship·Pharma·Pharmaceutical industry·research·Thought Leaders·Trends
By DJ Edgerton
WebMD – sine qua non, in online health information. Over 40 million people enter a WebMD search – every month. US News & World Report called it “the Mall of America of health web sites”. Without WebMD, would there be health information on the internet? Sure… but it’s hard to imagine.
And actually, the [...]
Tags:Communities·data·Health care·Healthcare Information Providers·media·Patients·Pharma·Thought Leaders·User Experience·Websites
By Guy Mastrion
If you need us here at P&P to tell you that the times they are a-changin… you need more than a blog to help you out.
How many big-pharma mergers and takeovers have we seen this year? Genentech and Roche. Merck and Schering. Pfizer and Wyeth. Pipelines are dry and they need new ideas [...]
Tags:Non-Profit·Patients·Pharma·Pharmaceutical industry·Thought Leaders·Trends·user needs
Paul Roellig, CEO of BulletinNEWS explains how restrictions on advertising and social media by the FDA could impact the medical publishing business and cut off valuable sources of information for healthcare professionals.
Tags:#fdasm·advertising·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·drug safety·Education·FDA·Legal Issues·marketing·media·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
Robert Winder, CEO of VuMedi talks about educating Health Care Professionals and how company concerns about FDA Regulations can actually impede information distribution.
Tags:#fdasm·advertising·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·drug safety·Education·FDA·Legal Issues·marketing·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
Mark Senak, SVP of Fleishman-Hillard and author of the EYE ON FDA blog declares “the system is broken” and offers the FDA some advice on how to deal with the media.
Tags:#fdasm·advertising·Blogs·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·drug safety·Education·FDA·Legal Issues·marketing·media·Pharma·social media·Thought Leaders·Trends
Live (almost) from the FDA hearings in Washington, Fard Johnmar founder of Envision Solutions explains how research can give us greater insight in to consumer use of social media (and how the FDA can utilize this information).
Tags:advertising·communication·Communities·Compliance·Conferences·data·digital strategy·Digital Tools·drug safety·FDA·Legal Issues·marketing·media·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
John Kamp of the AAAA’s of the Coalition for Healthcare Communication talks about advertising & social media and how they can help the FDA educate healthcare consumers.
Tags:#fdasm·advertising·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·drug safety·Education·FDA·marketing·media·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
